A New Cycler for Automated Peritoneal Dialysis to Provide Efficient Dialysis and Improved Sleep Quality.

Automated peritoneal dialysis Cycler Dialysis dose Patient-reported outcomes Sleep quality

Journal

Blood purification
ISSN: 1421-9735
Titre abrégé: Blood Purif
Pays: Switzerland
ID NLM: 8402040

Informations de publication

Date de publication:
2023
Historique:
received: 19 09 2022
accepted: 13 03 2023
medline: 13 9 2023
pubmed: 19 6 2023
entrez: 18 6 2023
Statut: ppublish

Résumé

Automated peritoneal dialysis (APD) employs cyclers to control inflow and outflow of the dialysis fluid to the patient's abdomen. To allow more patients to use this modality, cyclers should support the achievement of an adequate dialysis dose and be easy to use, cost-effective, and silent. The new SILENCIA cycler (Fresenius Medical Care, Bad Homburg, Germany), designed to improve these characteristics in comparison to its predecessor device, was evaluated in this respect in a prospective study. This cross-over study comprised two 2-week study periods, separated by a 3-week training phase. First, patients underwent APD with their current cycler (PD-NIGHT [Fresenius Medical Care, Bad Homburg, Germany] or HomeChoice Pro [Baxter, Deerfield, IL, USA] as control), followed by training on the SILENCIA cycler. Then, patients were switched to the SILENCIA cycler. During each treatment period, we collected data on total Kt/Vurea, ultrafiltration (UF) volume, patient-reported outcomes (sleep quality, among others), and device handling. Sixteen patients were enrolled; 2 patients terminated the study prematurely before study intervention, 1 patient due to a protocol violation. In 13 patients, total Kt/Vurea and UF could be evaluated. Neither Kt/Vurea nor UF differed significantly between control and SILENCIA cyclers. Out of 10 patients answering the questionnaire on sleep quality after the 2-week phase with the SILENCIA cycler, sleep quality improved in 5 patients; in the other patients, sleep quality was rated unchanged compared to the previously used cycler. The average reported sleep time was 5.9 ± 1.8 h with the PD-NIGHT, 7.2 ± 2.1 h with HomeChoice Pro, and 8.0 ± 1.6 h with the SILENCIA cycler. All patients were much or very much satisfied with the new cycler. The SILENCIA cycler delivers adequate urea clearance and UF. Importantly, sleep quality improved, possibly related to less caution messages and alarms.

Identifiants

pubmed: 37331338
pii: 000530464
doi: 10.1159/000530464
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

668-675

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Rubén Torres (R)

NephroCare Independencia, Santiago, Chile.

Lorena Flores (L)

NephroCare San Bernardo & NephoCare Providencia, Santiago, Chile.

Miguel Morales (M)

NephroCare La Serena, La Serena, Chile.

Rina Morales (R)

NephroCare Chile, Santiago, Chile.

Eduardo Machuca (E)

NephroCare Chile, Santiago, Chile.

Adelheid Gauly (A)

Fresenius Medical Care Deutschland GmbH, Global Medical Office, Bad Homburg, Germany.

Saynab Atiye (S)

Fresenius Medical Care Deutschland GmbH, Global Medical Office, Bad Homburg, Germany.

Manuela Stauss-Grabo (M)

Fresenius Medical Care Deutschland GmbH, Global Medical Office, Bad Homburg, Germany.

Tatiana De Los Ríos (T)

Fresenius Medical Care Deutschland GmbH, Global Medical Office, Bad Homburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH